We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan.
- Authors
Peng, Hsin‐Hui; Ko, Hui‐Hsin; Chi, Nai‐Chi; Wang, Yi‐Ping; Lee, Hsiang‐Chieh; Pan, Pei‐Yao; Kuo, Mark Yen‐Ping; Cheng, Shih‐Jung
- Abstract
Background: Nucleophosmin/nucleoplasmin family 1 (NPM1) has broad physiological functions, such as DNA replication, transcription, ribosome biogenesis, and centrosome replication. This study explored the clinicopathological importance of NPM1 as a prognostic marker for oral squamous cell carcinoma (OSCC). Methods: We collected specimens from 96 OSCC, 45 oral epithelial dysplasia (OED), and 29 normal oral mucosa (NOM). NPM1 expression was analyzed via immunohistochemistry. Correlations between NPM1and clinical parameters were analyzed using Student t test, chi‐squared test, and Kaplan‐Meier product‐limit method. Results: The NPM1 labeling indices (LIs) were significantly higher in OSCCs than in NOM and oral OED. Higher NPM1 expression was significantly correlated with larger tumor size, nodal metastasis, and advanced clinical stage. Multivariate analysis revealed that higher NPM1 LIs were an unfavorable independent factor for survival. Conclusions: Upregulated NPM1 is an independent biomarker of poor prognosis and NPM1 inhibitors may be promising in molecular targeted therapy against OSCC.
- Subjects
TAIWAN; SQUAMOUS cell carcinoma; ORGANELLE formation; DNA replication; ORAL mucosa; CHI-squared test; MOUTH tumors
- Publication
Head & Neck, 2020, Vol 42, Issue 1, p5
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.25971